​

Verrica Pharmaceuticals Ownership | Who Owns Verrica Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Verrica Pharmaceuticals Ownership Summary

Verrica Pharmaceuticals is owned by 22.30% institutional investors, 49.00% insiders, and 28.70% retail investors. Caligan partners lp is the largest institutional shareholder, holding 8.67% of VRCA shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 1.26% of its assets in Verrica Pharmaceuticals shares.

VRCA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVerrica Pharmaceuticals22.30%49.00%28.70%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Caligan partners lp923.91K8.67%$4.89M
Affinity asset advisors707.34K6.64%$3.74M
Cannell capital685.12K6.43%$3.62M
Armistice capital518.18K4.86%$2.74M
Velan capital investment management lp471.56K4.43%$2.49M
Boothbay fund management280.73K2.64%$1.49M
Blackrock1.13M2.43%$8.23M
Vanguard group138.19K1.46%$1.15M
Dafna capital management153.71K1.44%$813.14K
Geode capital management138.92K1.30%$734.97K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cannell capital685.12K2.23%$3.62M
Velan capital investment management lp471.56K1.56%$2.49M
Caligan partners lp923.91K0.33%$4.89M
Stonepine capital management99.73K0.21%$527.60K
Affinity asset advisors707.34K0.19%$3.74M
Dafna capital management153.71K0.18%$813.14K
Verdad advisers, lp12.10K0.07%$64.00K
Armistice capital518.18K0.05%$2.74M
Boothbay fund management280.73K0.02%$1.49M
Legacy trust17.23K0.02%$91.17K

Top Buyers

HolderShares% AssetsChange
Cannell capital685.12K2.23%685.12K
Geode capital management138.92K-71.26K
Vanguard fiduciary trust65.10K0.00%65.10K
Blackrock funding, inc. /de38.55K-32.87K
Blackrock1.13M0.00%15.08K

Top Sellers

HolderShares% AssetsChange
Avoro capital advisors---4.00M
Perceptive advisors---3.25M
Armistice capital518.18K0.05%-600.74K
Heights capital management---351.14K
Propel bio management---344.94K

New Positions

HolderShares% AssetsChangeValue
Cannell capital685.12K2.23%685.12K$3.62M
Vanguard fiduciary trust65.10K0.00%65.10K$344.38K
Aqr capital management14.44K-14.44K$10.11K
Verdad advisers, lp12.10K0.07%12.10K$64.00K
Vanguard global advisers862.00-862.00$4.56K

Sold Out

HolderChange
Barclays-1.00
Mai capital management-2.00
Group one trading-3.00
Nelson, van denburg & campbell wealth management group-4.00
True wealth design-8.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20264412.82%4,751,054-0.56%224.43%16-1271.43%
Mar 31, 202613-73.47%338,440-93.49%30.11%4-85.19%2-80.00%
Dec 31, 2025333.13%2,435,253-1.39%253.79%18157.14%7-70.83%
Sep 30, 20251-98.08%568-100.00%-0.00%--100.00%--100.00%
Jun 30, 202552-27.78%24,696,020-16.20%262.70%23-41.03%20100.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard MStar Total Stk Mkt Idx Invest216.44K1.26%72.86K
Invesco Dorsey Wright SmallCap Momt ETF409.00K0.96%-
Vanguard US Total Market Shares ETF815.89K0.89%-
Vanguard Total Stock Mkt Idx Inv143.58K0.84%21.03K
Vanguard Morn Total Stk Mkt Idx Investor143.58K0.84%21.03K
Vanguard Institutional Extnd Mkt Idx Tr135.47K0.79%-
Fidelity Select Biotechnology517.63K0.57%-112.24K
iShares Russell 2000 ETF520.96K0.56%-
Simplify Propel Opportunities ETF200.00K0.44%-
Fidelity Small Cap Index385.38K0.42%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 17, 2026Zawitz David Chief Operating OfficerBuy$29.88K
Aug 18, 2026Rosenberg Noah L. CMOBuy$9.99K
Aug 17, 2026Rieger Jayson CEO and PresidentBuy$24.55K
Aug 14, 2026Rieger Jayson CEO and PresidentBuy$101.20K
Aug 17, 2026Rosenberg Noah L. CMOBuy$20.62K

Insider Transactions Trends

DateBuySell
2026 Q36-
2026 Q2--
2025 Q412-
2025 Q2--
2025 Q1-1

VRCA Ownership FAQ

Who Owns Verrica Pharmaceuticals?

Verrica Pharmaceuticals shareholders are primarily institutional investors at 22.30%, followed by 49.00% insiders and 28.70% retail investors. The average institutional ownership in Verrica Pharmaceuticals's industry, Biotech Stocks , is 379.61%, which Verrica Pharmaceuticals falls below.

Who owns the most shares of Verrica Pharmaceuticals?

Verrica Pharmaceuticals’s largest shareholders are Caligan partners lp (923.91K shares, 8.67%), Affinity asset advisors (707.34K shares, 6.64%), and Cannell capital (685.12K shares, 6.43%). Together, they hold 21.75% of Verrica Pharmaceuticals’s total shares outstanding.

Does Blackrock own Verrica Pharmaceuticals?

Yes, BlackRock owns 2.43% of Verrica Pharmaceuticals, totaling 1.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.23M$. In the last quarter, BlackRock increased its holdings by 15.08K shares, a 1.35% change.

Who is Verrica Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Cannell capital is Verrica Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.23% of its assets in 685.12K Verrica Pharmaceuticals shares, valued at 3.62M$.

Who is the top mutual fund holder of Verrica Pharmaceuticals shares?

Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund holder of Verrica Pharmaceuticals shares, with 1.26% of its total shares outstanding invested in 216.44K Verrica Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools